Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2026-06-18 16:11:23 ET · period of report 2026-06-16 · accession 0001610717-26-000247 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-18 16:11 | 2026-06-16 | RVMD | Mancini Anthony | See Remarks | S - Sale | $156.12 | -4,615 | 50.0K | -8% | -$720.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-16 | S | D | 4,615 | $156.12 | 49,975 | D | — | — | (F1) Pursuant to an automatic sell-to-cover, the shares were sold following the vesting of the restricted stock units solely to cover applicable withholding taxes. (F2) This transaction was executed in multiple trades at prices ranging from $156.1105 to $156.8250. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F3) Includes 43,700 Restricted Stock Units. (F4) Includes 190 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2026. |